Terbinafine (250 mg/day): An effective and safe treatment of cutaneous sporotrichosis

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 11, 2009, Pages 1273-1276

  Francesconi, G ^a   Valle, Ac ^a   Passos, S ^b   Reis, R ^a   Galhardo, Mc ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Itraconazole; Sporotrichosis; Terbinafine; Treatment

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DIGOXIN; INOTROPIC AGENT; ITRACONAZOLE; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; TERBINAFINE;

ADULT; AGED; ARTICLE; CAT; CLINICAL ARTICLE; COMORBIDITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERSENSITIVITY; MALE; MYCOSIS; PRIORITY JOURNAL; RASH; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS;

ANTIFUNGAL AGENTS; HUMANS; NAPHTHALENES; SPOROTRICHOSIS;

EID: 70349956647     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03306.x     Document Type: Article

References (20)

1. Conti Diaz IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia 1989 108 : 113 116.
2. Kusuhara M, Hachisuka H, Sasai Y. Statistical survey of 150 cases with sporotrichosis. Mycopathologia 1988 102 : 129 133.
3. Kwon-Chung KJ, Benett JE. Sporotrichosis. In Kwon-Chung KJ, Benett JE, eds. Medical Mycology. Lea & Febiger, Philadelphia, 1992 : 707.
4. Pappas PG, Tellez I, Deep AE et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 2000 30 : 65 70.
5. Kauffman CA, Bustamante B, Chapman SW et al. Clinical practice guidelines for the management of sporotrichosis: 2007 Update by the Infetious Diseases Society of America. Clin Infect Dis 2007 45 : 1255 1265.
6. Micromedex DrugDex E MARTINDALE Terbinafine - The Complete Drug Reference http://www.thomsonhc.com/hcs/librarian/ND-PR/Main/SBK/2/PFPUI/BpY1SQ1yTn4wf/ND- PG/PRIH/CS/97A06F/ND-T/HCS/ND-P/Main/DUPLICATIONSHIELDSYNC/5B2E6F/ND-B/HCS/ PFActionId/hcs.common.RetrieveDocumentCommon/DocId/2679p/ContentSetId/30/ SearchTerm/terbinafine/SearchOption/BeginWithReference (last accessed 12 December 2008).
7. Chapman SW, Pappas P, Kauffmann C et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 2004 47 : 62 68.
8. Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999 141 (Suppl. 56 36 40.
9. Hull PR, Vismer HF. Treatment of cutaneous sporotrichosis with terbinafine. Br J Dermatol 1992 126 (Suppl. 39 51 55.
10. Tanuma H, Asai T, Abe M. Case Report. Lymphatic vessel-type sporotrichosis immunohistochemical evaluation and cytokine expression pattern. Mycoses 2001 44 : 316 320.
11. Terbinafine Study Group. Clinical evaluation of terbinafine, an orally active antifungal agent for rare types of dermatomycosis with terbinafine. Nishihon J Dermatol 1994 56 : 584 594.
12. Barros MB, Schubach AO, Valle AC et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004 38 : 529 535.
13. Barros MB, Schubach AO, Galhardo MCG et al. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol 2003 42 : 677 681.
14. Micromedex DrugDex. E MARTINDALE Itraconazole-The Complete Drug Reference http://www.thomsonhc.com/hcs/librarian/ND-PR/Main/SBK/2/PFPUI/BpY1SQ1yTn4wf/ND- PG/PRIH/CS/97A06F/ND-T/HCS/ND-P/Main/DUPLICATIONSHIELDSYNC/5B2E6F/ND-B/HCS/ PFActionId/hcs.common.RetrieveDocumentCommon/DocId/2679p/ContentSetId/30/ SearchTerm/Itraconazole/SearchOption/BeginWithReference (last accessed 12 December 2008).
15. Galhardo MC, De Oliveira RM, Valle ACF et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 2008 46 : 141 151.
16. Kohler LM, Monteiro PC, Hahn RC et al. In vitro susceptibilities of isolates of Sporothrix schenckii to ITC and terbinafine. J Clin Microbiol 2004 42 : 4319 4320.
17. Coskun B, Saral Y et al. Sporotrichosis successfully treated with terbinafine and potassium iodine: Case report and review of literatura. Mycopathologia 2004 158 : 53 56.
18. Bustamante B, Campos PE. Sporotrichosis: a forgotten disease in the drug research agenda. Expert Rev Anti Infect Ther 2004 2 : 85 94.
19. Bub JL, Olerud JE. Diabetes Mellitus. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz I. Fitzpatrick's Dermatology in General Medicine, 6th edn. McGrawHill, United Sates of America, 2003 : 1651.
20. Sandoz Pharmaceuticals Corporation. US product monograph on terbinafine (Lamisil). East Hanover, NJ. Sandoz Pharmaceuticals Corporation, April 1996.